Newsletter registration

Austria.
Bridge to New Markets.

Success for the startup Zytoprotec

APA © APA

In contrast to hemodialysis, peritoneal dialysis can be carried out by patients themselves, thus increasing their mobility and independence. However, infections and chronic inflammation often results from this type of treatment, leading to a termination of the treatment in most cases. Zytoprotec promises to counteract this damaging mechanism thanks to its dialysis solution PD-protec, which also improves the effectiveness of the peritoneal dialysis. The active agent alanyl-glutamine is currently being tested in a Phase II clinical study, the results of which are expected to be available in the fall of 2016. According to the business plan of the company, the project or the company is expected to be sold in the course of the year 2017, comprising an exit for the investors.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us at: Family Business Network IFR

    07.03.2018, Katowice, Poland

  • Consultation Day for Slovak Companies

    13.03.2018, Bratislava, Slovakia

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

ABA achieves new all-time high with 344 international business location projects

Germany once again number one followed by Italy, Switzerland and Slovenia – Higher volume of investments and new jobs.

Carnival in Austria

Witches, demons and other spooky creatures populate the streets of Austria up until Ash Wednesday. However, nobody has to be afraid. This period of year is mainly colorful, funny and sometimes a bit crazy.

More news All blog posts